Table 1 Study characteristics, surgical details and postoperative outcomes of included full-text articles
Study characteristics* | Surgical details | Postoperative outcomes* | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Author & Year | Country | Study period | Sample size | Mean age | Male (%) | Surgical technique | Appr | Mesh repair | Mesh position | Mesh type | Post-OP compl. rate | CD Grade  > II | Rec. rate | Length of follow-up | Type of follow-up | Length of stay | 30-day re-operation rate |
Franks 2001 | USA | NR | 6 | (65–83) | NR | Keyhole | Open | Yes | Onlay | small pore, heavy weight | NR | NR | 0% | 26 m (2–42) | Clinical + CT | 2.5 d (2–5) | 0% |
Helal 1997 | USA | 1990–1996 | 19 | 64.3(41–79) | 26% | Re- location | Open | Yes (†) | Onlay | small pore, heavy weight | NR | NR | 11% | 23.4 ± 15.25 m | NR | NR | NR |
Ho 2004 | UK | 1982–2001 | 15 | (34–82) | 47% | Onlay mesh repair (‡) | Open | Yes | Onlay | small pore, heavy weight | 13% | 13% | 7% | 15 m (1–72) | NR | 4 d (2–14) | 13% |
Lopez-Cano 2021 | Spain | 2012–2018 | 20 | 71 (SD:9.07) | 85,0% | Onlay mesh repair | Open (16) Lap. (4) | Yes | Onlay | synthetic, non- absorbable | 45.0% | 10.0% | NR | 6 m | NR | NR | NR |
Mäkäräinen- Uhlbäck** 2021 | Finland | 2007–2017 | 18 (KH) | 70 ± 9 | 44,4% | Keyhole | Open (7) Lap. (11) | Yes | NR | NR | 33.3% | 11.1% | 22.2% | 49 m ± 34 | NR | 17.8 ± 50.1 days | 5.6% |
10 (SB) | 77 ± 6 | 60,0% | Sugar- baker | Open (2) Lap. (8) | Yes | NR | NR | 10.0% | 0.0% | 10.0% | 27 m ± 21 | NR | 6.3 ± 3.7 days | 0.0% | |||
Rodriguez- Faba 2011 | Spain | 2000–2006 | 19 | 63 (49–79) | 84% | Re- location | Open | Yes (§) | Intra- peritoneal | large pore, light weight | 26% | 5% | 21% | 55 m | NR | 7 d(1–25) | 5% |
Safadi 2004 | USA | 1998–2001 | 5 | 66 (54–77) | 100% | Keyhole | Lap | Yes | Intra- peritoneal | ePTFE | 0% | 0% | 80% | 11.6 m (6–10) | Clinical | 4.4 d (2–6) | 0% |
Tully 2019 | Germany | 2009–2015 | 40 | NR | 63% | 3D funnel shape | Open | Yes | Intra- peritoneal | large pore, light weight | 3% | 3% | 7% | 29 m (IQR 16–63) | Clinical + US | NR | 0% |